WO2003020985B1 - Detection of genetic sequences using a bipartite probe - Google Patents

Detection of genetic sequences using a bipartite probe

Info

Publication number
WO2003020985B1
WO2003020985B1 PCT/US2002/027865 US0227865W WO03020985B1 WO 2003020985 B1 WO2003020985 B1 WO 2003020985B1 US 0227865 W US0227865 W US 0227865W WO 03020985 B1 WO03020985 B1 WO 03020985B1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
nucleic acid
hybridizing
detectable amplification
amplification molecule
Prior art date
Application number
PCT/US2002/027865
Other languages
French (fr)
Other versions
WO2003020985A1 (en
Inventor
Timothy A Hodge
Shawn O'malley
Original Assignee
Transnetyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transnetyx Inc filed Critical Transnetyx Inc
Publication of WO2003020985A1 publication Critical patent/WO2003020985A1/en
Publication of WO2003020985B1 publication Critical patent/WO2003020985B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00722—Communications; Identification
    • G01N35/00871—Communications between instruments or with remote terminals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N1/31—Apparatus therefor
    • G01N1/312—Apparatus therefor for samples mounted on planar substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/025—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having a carousel or turntable for reaction cells or cuvettes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00351—Means for dispensing and evacuation of reagents
    • B01J2219/00387—Applications using probes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00527—Sheets
    • B01J2219/00533—Sheets essentially rectangular
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00659—Two-dimensional arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Abstract

The present invention concerns a method to improve detection or quantification of a genetic sequence in a genetic sample using a bipartite probe. A bipartite probe is made of a nucleic acid binding sequence capable of hybridizing a target genetic sequence and a binding probe sequence capable of hybridizing to a detectable amplification molecule through a nucleic acid sequence capable of hybridizing to the binding probe sequence of the bipartite probe. The amplification molecule (6) can be a dendriver that includes a label in its core and/or on any of its arms. Moreover, a secondary signal generation molecule (11) may also be added to the mixture to further increase signal. Similarly, tertiary (20) and quaternary (30), etc. amplification molecules may successively be added to yield increase signal.

Claims

AMENDED CLAIMS
[received by the International Bureau on 4 March 2003 (04.03.03); new claims 1, 16, 20, 24 and 26 replace one or more original claims; claim 7 cancelled, claims 2-6, 8-15, 17-19, 22-23 and 25 unchanged (3 pages)]
IN THE CLAIMS:
I. A method for detection or quantitation of a target genomic sequence in a genetic sample an assay which comprises using:
(a) a bipartite probe consisting essentially of a target nucleic acid binding sequence capable of hybridizing said target genomic sequence and an nucleic acid binding probe sequence capable of hybridizing with a nucleic acid sequence of a primary detectable amplification molecule; and
(b) a primary detectable amplification molecule consisting essentially of a nucleic acid sequence capable of hybridizing the binding probe sequence of said bipartite probe.
II. The method of claim 1 wherein said primary amplification molecule further consists of a nucleic acid binding sequence capable of hybridizing a labeled genetic sequence.
III. The method of claim 2 wherein said labeled genetic sequence is a single stranded oligonucleotide.
IV. The method of claim 2 wherein said primary detectable amplification molecule further consists of a nucleic acid sequence capable of hybridizing to a secondary detectable amplification molecule.
V. The method of claim 4 wherein said secondary detectable amplification molecule is a dendrimer.
VI. The method of claim 1 wherein said primary detectable amplification molecule is a dendrimer.
VII. The method of claim 2 wherein the label of said labeled genetic sequence is selected from the group consisting of enzymes, radioactive isotopes, flurogenic, chemiluminescent, electrochemical materials and members of a specific binding pair.
VIII. The method of claim 1 wherein said method further consists of sequentially hybridizing a second detectable amplification molecule.
34 IX. The method of claim 9 wherein said method further consists of sequentially hybridizing a third detectable amplification molecule.
X. The method of claim 10 wherein said method further consists of sequentially hybridizing a fourth detectable amplification molecule.
XI. The method of claim 1 wherein the said target nucleic acid binding sequence for a eukaryotic organism ranges from between 16 to 20 bases.
XII. The method of claim 1 wherein the said nucleic acid binding sequence for a prokaryotic organism ranges from between 8 to 13 bases.
XIII. The method of claim 1 wherein the said nucleic acid binding sequence is 31 bases.
XIV. The method of claim 1 wherein the said nucleic acid binding probe sequence of the secondary amplification molecule is 31 bases in length.
XV. A method to increase signal strength in an assay for a target genomic sequence in a genetic sample comprising: hybridizing at least one detectable amplification molecule with a bipartite probe in a hybridization solution, said bipartite probe consisting essentially of a target nucleic acid binding sequence capable of hybridizing said target genomic sequence and a binding probe sequence capable of hybridizing with a nucleic acid sequence of at least one detectable amplification molecule.
XVI. The method of claim 16 wherein said at least one detectable amplification molecule includes at least one capture arm.
XVII. The method of claim 17 wherein said at least one capture arm is between 16 to 90 bases.
XVIII. The method of claim 16 wherein said at least one detectable amplification molecule is a dendrimer.
XIX. A method to increase signal strength in an assay for a target genomic sequence in a genetic sample comprising: hybridizing primary and secondary detectable amplification molecules in a hybridization solution and adding a bipartite probe said bipartite probe consisting essentially of a target nucleic acid binding sequence capable of hybridizing said
35 target genomic sequence and a binding probe sequence capable of hybridizing with a nucleic acid sequence of at least one detectable amplification molecule.
XX. The method of claim 20 wherein said primary and secondary detectable amplification molecules are dendrimers.
XXI. The method of claim 20 wherein said detectable amplification molecules include at least one capture arm.
XXII. The method of claim 20 wherein said capture arms are between 16 to 90 bases.
XXIII. A method of forensic analysis for a target nucleic acid sequence comprising:
(a) isolating human genomic DNA;
(b) immobilizing said human genomic DNA on a flat substrate;
(c) hybridizing said human genomic DNA with a bipartite probe consisting essentially of a target nucleic acid binding sequence capable of hybridizing said target genomic sequence and a binding probe sequence capable of hybridizing with a nucleic acid sequence of a primary detectable amplification molecule; and a primary detectable amplification molecule consisting essentially of a nucleic acid sequence capable of hybridizing the binding probe sequence of said bipartite probe;
(d) detecting said detectable amplification molecule; and
(e) correlating said detectable amplification molecule with said target nucleic acid sequence.
XXIV. The method of claim 24 wherein said target nucleic acid sequence is polymorphism in the variable number of tandem repeats of the human genome.
XXV. The method of claim 24 wherein said target nucleic acid binding sequence capable of hybridizing said target genomic sequence comprises SEQ ID NO: 30.
PCT/US2002/027865 2001-09-04 2002-09-03 Detection of genetic sequences using a bipartite probe WO2003020985A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/945,952 2001-09-04
US09/945,952 US7011943B2 (en) 2000-09-06 2001-09-04 Method for detecting a designated genetic sequence in murine genomic DNA

Publications (2)

Publication Number Publication Date
WO2003020985A1 WO2003020985A1 (en) 2003-03-13
WO2003020985B1 true WO2003020985B1 (en) 2003-05-01

Family

ID=25483747

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/027865 WO2003020985A1 (en) 2001-09-04 2002-09-03 Detection of genetic sequences using a bipartite probe

Country Status (4)

Country Link
US (4) US7011943B2 (en)
EP (1) EP1978110B1 (en)
TW (2) TWI322187B (en)
WO (1) WO2003020985A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001031333A1 (en) * 1999-10-26 2001-05-03 Genometrix Genomics Incorporated Process for requesting biological experiments and for the delivery of experimental information
CA2290731A1 (en) 1999-11-26 2001-05-26 D. Jed Harrison Apparatus and method for trapping bead based reagents within microfluidic analysis system
US6432290B1 (en) 1999-11-26 2002-08-13 The Governors Of The University Of Alberta Apparatus and method for trapping bead based reagents within microfluidic analysis systems
US7494817B2 (en) 2000-09-06 2009-02-24 Transnet Yx, Inc. Methods for genotype screening using magnetic particles
US20030082605A1 (en) * 2000-09-06 2003-05-01 Hodge Timothy A. Genomic DNA detection method and system thereof
US20050272085A1 (en) * 2000-09-06 2005-12-08 Hodge Timothy A Methods for forensic and congenic screening
US20030087286A1 (en) * 2000-09-06 2003-05-08 Hodge Timothy A. Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
US20050239125A1 (en) * 2000-09-06 2005-10-27 Hodge Timothy A Methods for genotype screening
US20050266494A1 (en) * 2000-09-06 2005-12-01 Hodge Timothy A System and method for computer network ordering of biological testing
EP1978110B1 (en) * 2000-09-06 2010-05-26 Transnetyx, Inc. Computer-based method and system for screening genomic DNA
US20030207289A1 (en) * 2001-09-04 2003-11-06 Hodge Timothy A. Detection of genetic sequences using a bipartite probe
US20060014186A1 (en) * 2001-09-04 2006-01-19 Hodge Timothy A Methods for genotype screening of a strain disposed on an adsorbent carrier
US8155886B2 (en) * 2002-08-07 2012-04-10 Cerner Innovation, Inc. Automated clinical system to facilitate secondary review and authentication of clinical laboratory result values
US7648678B2 (en) 2002-12-20 2010-01-19 Dako Denmark A/S Method and system for pretreatment of tissue slides
WO2004061085A2 (en) * 2002-12-30 2004-07-22 The Regents Of The University Of California Methods and apparatus for pathogen detection and analysis
US7799553B2 (en) 2004-06-01 2010-09-21 The Regents Of The University Of California Microfabricated integrated DNA analysis system
JP4476050B2 (en) * 2004-06-30 2010-06-09 株式会社ニデック Perimeter
EP1794581A2 (en) 2004-09-15 2007-06-13 Microchip Biotechnologies, Inc. Microfluidic devices
CH703675B1 (en) * 2005-11-16 2012-03-15 Suisse Electronique Microtech Process for producing J aggregates
WO2008030631A2 (en) 2006-02-03 2008-03-13 Microchip Biotechnologies, Inc. Microfluidic devices
US7766033B2 (en) 2006-03-22 2010-08-03 The Regents Of The University Of California Multiplexed latching valves for microfluidic devices and processors
ATE517192T1 (en) * 2006-08-10 2011-08-15 Merck Patent Gmbh METHOD FOR ISOLATION OF CELLS
US8841116B2 (en) 2006-10-25 2014-09-23 The Regents Of The University Of California Inline-injection microdevice and microfabricated integrated DNA analysis system using same
WO2008115626A2 (en) 2007-02-05 2008-09-25 Microchip Biotechnologies, Inc. Microfluidic and nanofluidic devices, systems, and applications
JP4887174B2 (en) * 2007-02-19 2012-02-29 株式会社日立ハイテクノロジーズ Automatic analyzer
US8454906B2 (en) 2007-07-24 2013-06-04 The Regents Of The University Of California Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions
WO2009108260A2 (en) 2008-01-22 2009-09-03 Microchip Biotechnologies, Inc. Universal sample preparation system and use in an integrated analysis system
WO2009103068A1 (en) * 2008-02-15 2009-08-20 Life Technologies Corporation Methods and compositions for shearing of polymers by sonication
US8731956B2 (en) * 2008-03-21 2014-05-20 Signature Genomic Laboratories Web-based genetics analysis
US8954337B2 (en) * 2008-11-10 2015-02-10 Signature Genomic Interactive genome browser
KR20110111449A (en) 2008-12-31 2011-10-11 인터젠엑스 인크. Instrument with microfluidic chip
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
US20100233704A1 (en) * 2009-02-25 2010-09-16 Cepheid Methods of detecting lung cancer
CN102459565A (en) 2009-06-02 2012-05-16 尹特根埃克斯有限公司 Fluidic devices with diaphragm valves
JP2012529268A (en) 2009-06-05 2012-11-22 インテジェンクス，インコーポレイテッド Use of universal sample preparation system and integrated analysis system
US8584703B2 (en) * 2009-12-01 2013-11-19 Integenx Inc. Device with diaphragm valve
US8512538B2 (en) 2010-05-28 2013-08-20 Integenx Inc. Capillary electrophoresis device
CN103153466B (en) 2010-07-22 2016-04-13 基因细胞生物系统有限公司 Composite fluid pond
WO2012024658A2 (en) 2010-08-20 2012-02-23 IntegenX, Inc. Integrated analysis system
WO2012024657A1 (en) 2010-08-20 2012-02-23 IntegenX, Inc. Microfluidic devices with mechanically-sealed diaphragm valves
WO2012103355A2 (en) 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
US20150136604A1 (en) 2011-10-21 2015-05-21 Integenx Inc. Sample preparation, processing and analysis systems
US10865440B2 (en) 2011-10-21 2020-12-15 IntegenX, Inc. Sample preparation, processing and analysis systems
DK2831587T3 (en) 2012-03-27 2018-07-23 Ventana Med Syst Inc Signaling conjugates and methods of use
DE102012102918A1 (en) * 2012-04-03 2013-10-10 Eppendorf Ag Laboratory device system and laboratory device for treating fluids and solids, and method for operating a laboratory device
CN104812492A (en) 2012-11-27 2015-07-29 基因细胞生物系统有限公司 Handling liquid samples
US20140272971A1 (en) * 2013-03-14 2014-09-18 Health Diagnostic Laboratory, Inc. Unheated extraction of genomic dna in an automated laboratory system
CN105873681B (en) 2013-11-18 2019-10-11 尹特根埃克斯有限公司 Cartridge and instrument for sample analysis
WO2015120398A1 (en) * 2014-02-10 2015-08-13 Gencell Biosystems Limited Composite liquid cell (clc) mediated nucleic acid library preparation device, and methods for using the same
WO2015179098A1 (en) 2014-05-21 2015-11-26 Integenx Inc. Fluidic cartridge with valve mechanism
EP3552690A1 (en) 2014-10-22 2019-10-16 IntegenX Inc. Systems and methods for sample preparation, processing and analysis
CA3005265A1 (en) * 2015-12-31 2017-07-06 Counsyl, Inc. Robotic system for sorting sample tubes
US11361847B1 (en) 2021-02-06 2022-06-14 Timothy A. Hodge System and method for rapidly reporting testing results
CN116024320A (en) * 2022-07-13 2023-04-28 上海翔琼生物技术有限公司 Fluorescent quantitative PCR method for detecting nucleic acid

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154795A (en) * 1976-07-23 1979-05-15 Dynatech Holdings Limited Microtest plates
US4628037A (en) 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US4695393A (en) 1983-05-12 1987-09-22 Advanced Magnetics Inc. Magnetic particles for use in separations
US4672040A (en) 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4698302A (en) 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
EP0133286B1 (en) 1983-07-30 1988-10-26 Johannes Bendig Film processing machine
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US5656493A (en) 1985-03-28 1997-08-12 The Perkin-Elmer Corporation System for automated performance of the polymerase chain reaction
US4920213A (en) * 1985-06-20 1990-04-24 Biotechnology Research Partners, Ltd. Method and compositions useful in preventing equine influenza
US5721098A (en) 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
US5139744A (en) 1986-03-26 1992-08-18 Beckman Instruments, Inc. Automated laboratory work station having module identification means
US5175270A (en) * 1986-09-10 1992-12-29 Polyprobe, Inc. Reagents for detecting and assaying nucleic acid sequences
US6054266A (en) 1987-12-21 2000-04-25 Applied Biosystems, Inc. Nucleic acid detection with separation
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
CA1339731C (en) 1988-10-12 1998-03-17 Charles T. Caskey Multiplex genomic dna amplification for deletion detection
US5182203A (en) 1989-03-29 1993-01-26 E. I. Du Pont De Nemours And Company Bifunctional compounds useful in catalyzed reporter deposition
US5196306A (en) 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
US5413923A (en) * 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
US5355304A (en) 1990-01-30 1994-10-11 Demoranville Victoria E Clinical laboratory work-flow system which semi-automates validated immunoassay and electrophoresis protocols
GB9003253D0 (en) 1990-02-13 1990-04-11 Amersham Int Plc Precipitating polymers
IT1240870B (en) 1990-02-14 1993-12-17 Talent PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF HUMAN GENOMIC DNA
US5219991A (en) 1990-09-21 1993-06-15 The United States Of America As Represented By The Department Of Health And Human Services Macrophage stimulating protein
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5366896A (en) 1991-07-30 1994-11-22 University Of Virginia Alumni Patents Foundation Robotically operated laboratory system
US6055487A (en) * 1991-07-30 2000-04-25 Margery; Keith S. Interactive remote sample analysis system
US6192320B1 (en) 1991-07-30 2001-02-20 The University Of Virginia Patent Foundation Interactive remote sample analysis system
WO1993003150A1 (en) 1991-07-31 1993-02-18 Amoco Corporation Simultaneous shear and denaturation of nucleic acids
WO1993014200A1 (en) 1992-01-07 1993-07-22 Tsi Corporation Transgenic animal models for alzheimer's disease
US5888723A (en) 1992-02-18 1999-03-30 Johnson & Johnson Clinical Diagnostics, Inc. Method for nucleic acid amplification and detection using adhered probes
ATE205542T1 (en) 1992-03-04 2001-09-15 Univ California COMPARATIVE GENOME HYBRIDIZATION
GB9212164D0 (en) 1992-06-09 1992-07-22 Medical Res Council Preparation of nucleic acids
US5859230A (en) * 1992-07-30 1999-01-12 Genelabs Technologies, Inc. Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
DE4236708A1 (en) * 1992-10-30 1994-05-05 Bayer Ag Specific gene probes and methods for the diagnosis of Candida albicans
AU5546594A (en) 1992-11-06 1994-06-08 Abbott Laboratories Process control system for biological fluid testing
US5427910A (en) * 1992-12-09 1995-06-27 Compucyte Corporation Method of cytogenetic analysis
US5733753A (en) 1992-12-22 1998-03-31 Novo Nordisk A/S Amplification of genomic DNA by site specific integration of a selectable marker construct
US5527695A (en) 1993-01-29 1996-06-18 Purdue Research Foundation Controlled modification of eukaryotic genomes
ATE256735T1 (en) 1993-08-30 2004-01-15 Promega Corp COMPOSITIONS AND METHODS FOR PURIFYING NUCLEIC ACIDS
US5837865A (en) * 1993-10-15 1998-11-17 Trustees Of The University Of Pennsylvania Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
GB9323305D0 (en) 1993-11-11 1994-01-05 Medinnova Sf Isoaltion of nucleic acid
US5863726A (en) * 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
US5596089A (en) 1994-02-14 1997-01-21 Universite De Montreal Oligonucleotide probe and primers specific to bovine or porcine male genomic DNA
US5932780A (en) 1994-02-28 1999-08-03 Yissum Research Development Company Of Hebrew University Of Jerusalem Transgenic non-human animal assay system for anti-cholinesterase substances
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6037465A (en) 1994-06-14 2000-03-14 Invitek Gmbh Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials
US5864020A (en) * 1994-07-20 1999-01-26 Genentech, Inc. HTK ligand
US5658744A (en) * 1994-07-22 1997-08-19 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying patients having an altered immune status
US6800452B1 (en) 1994-08-08 2004-10-05 Science Applications International Corporation Automated methods for simultaneously performing a plurality of signal-based assays
US5705628A (en) 1994-09-20 1998-01-06 Whitehead Institute For Biomedical Research DNA purification and isolation using magnetic particles
AT401270B (en) 1994-09-26 1996-07-25 Immuno Ag METHOD FOR QUANTIFYING GENOMIC DNA
GB9425138D0 (en) * 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US5576197A (en) * 1995-04-07 1996-11-19 Molecular Bio-Products Polymerase chain reaction container and methods of using the same
DE19520398B4 (en) 1995-06-08 2009-04-16 Roche Diagnostics Gmbh Magnetic pigment
JP2965131B2 (en) * 1995-07-07 1999-10-18 東洋紡績株式会社 Magnetic carrier for nucleic acid binding and nucleic acid isolation method using the same
US5851599A (en) * 1995-09-28 1998-12-22 Sumitomo Electric Industries Co., Ltd. Battery electrode substrate and process for producing the same
US6114150A (en) 1995-11-29 2000-09-05 Yale University Amplification of nucleic acids
US5668548A (en) * 1995-12-28 1997-09-16 Philips Electronics North America Corp. High performance variable length decoder with enhanced throughput due to tagging of the input bit stream and parallel processing of contiguous code words
JP3735937B2 (en) * 1996-04-16 2006-01-18 宇部興産株式会社 Terminal cap and cylindrical non-aqueous secondary battery using them
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
EP1736554B1 (en) * 1996-05-29 2013-10-09 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6072043A (en) * 1996-06-04 2000-06-06 Polyprobe, Inc. Optimally fluorescent oligonucleotides
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US7098320B1 (en) * 1996-07-29 2006-08-29 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US5942402A (en) * 1996-08-02 1999-08-24 Smithkline Beecham Corporation Method of detecting and treating cancer
US5731095A (en) 1996-10-23 1998-03-24 Oxazogen, Inc. Dendritic polymer coatings
US6117631A (en) * 1996-10-29 2000-09-12 Polyprobe, Inc. Detection of antigens via oligonucleotide antibody conjugates
US5841975A (en) 1996-12-10 1998-11-24 The Regents Of The University Of California Method and apparatus for globally-accessible automated testing
US5968731A (en) 1996-12-10 1999-10-19 The Regents Of The University Of California Apparatus for automated testing of biological specimens
US6060240A (en) 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
US5837466A (en) 1996-12-16 1998-11-17 Vysis, Inc. Devices and methods for detecting nucleic acid analytes in samples
DE19653439A1 (en) 1996-12-20 1998-07-02 Svante Dr Paeaebo Methods for the direct, exponential amplification and sequencing of DNA molecules and their application
US6027945A (en) 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
US20050287583A1 (en) 1997-01-21 2005-12-29 Promega Corporation Methods and kits for isolating biological target materials using silica magnetic particles
DE69825601T2 (en) * 1997-02-12 2005-04-28 Chan, Eugene Y, Brookline METHOD FOR THE ANALYSIS OF POLYMERS
WO1998038510A2 (en) * 1997-02-28 1998-09-03 Burstein Laboratories, Inc. Laboratory in a disk
US20020012934A1 (en) 1997-03-07 2002-01-31 Meghen Ciaran N. Business method for identification of a meat product by genotyping
CA2283432A1 (en) 1997-03-07 1998-09-11 Parlanca Limited A method and system of identification of a meat product by genotyping
US5842573A (en) * 1997-03-11 1998-12-01 Halvorsen; Yuan-Di C. Method of transporting cells and kit useful therefor
IL120672A (en) 1997-04-15 2000-06-29 Nush Marketing Man And Consult System for transaction over communication network
DE69841139D1 (en) 1997-07-14 2009-10-22 Univ Liege MUTATIONS IN MYOSTATINGEN INCREASE MUSCLE MASS IN MAMMALS
ATE327344T1 (en) * 1997-07-29 2006-06-15 Polyprobe Inc DENDRITIC NUCLEIC ACIDS WITH MAXIMUM SELF-COLLECTIVE STORAGE
US6465178B2 (en) 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
EP1071691B1 (en) 1998-02-04 2005-09-28 MERCK PATENT GmbH Method for isolating and purifying nucleic acids
US6043039A (en) 1998-02-17 2000-03-28 Applied Spectral Imaging Method of and composite for in situ fluorescent hybridization
US6187537B1 (en) 1998-04-27 2001-02-13 Donald E. Zinn, Jr. Process and apparatus for forming a dry DNA transfer film, a transfer film product formed thereby and an analyzing process using the same
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
US6132685A (en) * 1998-08-10 2000-10-17 Caliper Technologies Corporation High throughput microfluidic systems and methods
US6203989B1 (en) * 1998-09-30 2001-03-20 Affymetrix, Inc. Methods and compositions for amplifying detectable signals in specific binding assays
US6480791B1 (en) 1998-10-28 2002-11-12 Michael P. Strathmann Parallel methods for genomic analysis
US5973138A (en) 1998-10-30 1999-10-26 Becton Dickinson And Company Method for purification and manipulation of nucleic acids using paramagnetic particles
DE19851156C1 (en) 1998-11-06 2000-04-27 Merck Patent Gmbh Isolation of plasmid DNA from a microbial culture comprises acidification and using particles to separate microbial cells from the culture
US6261779B1 (en) * 1998-11-10 2001-07-17 Bio-Pixels Ltd. Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
DE19856064C2 (en) * 1998-12-04 2000-11-30 Invitek Gmbh Universal method for the isolation of DNA from any starting material
US20030215821A1 (en) 1999-04-20 2003-11-20 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
CA2270106C (en) 1999-04-23 2006-03-14 Yousef Haj-Ahmad Nucleic acid purification and process
US6270970B1 (en) 1999-05-14 2001-08-07 Promega Corporation Mixed-bed solid phase and its use in the isolation of nucleic acids
US6180351B1 (en) * 1999-07-22 2001-01-30 Agilent Technologies Inc. Chemical array fabrication with identifier
US6362832B1 (en) * 1999-09-01 2002-03-26 Packard Bioscience Company Method and system for overlaying at least three microarray images to obtain a multicolor composite image
US6730023B1 (en) * 1999-10-15 2004-05-04 Hemopet Animal genetic and health profile database management
DE19955729A1 (en) * 1999-11-15 2001-05-23 Hospitalia Dienstleistungs & B Communication system for the interaction of medical laboratories and medical treatment facilities
US6274321B1 (en) * 1999-12-03 2001-08-14 The Regents Of The University Of California High throughput functional screening of cDNAs
WO2001043038A1 (en) * 1999-12-13 2001-06-14 Ppgx, Inc. Tracking of clinical study samples, information and results
US20030097222A1 (en) * 2000-01-25 2003-05-22 Craford David M. Method, system, and computer software for providing a genomic web portal
US6556923B2 (en) * 2000-01-26 2003-04-29 Caliper Technologies Corp. Software for high throughput microfluidic systems
US20030040870A1 (en) * 2000-04-18 2003-02-27 Brooke Anderson Automated system and process for custom-designed biological array design and analysis
US20030082605A1 (en) 2000-09-06 2003-05-01 Hodge Timothy A. Genomic DNA detection method and system thereof
US20050266494A1 (en) 2000-09-06 2005-12-01 Hodge Timothy A System and method for computer network ordering of biological testing
US20050239125A1 (en) 2000-09-06 2005-10-27 Hodge Timothy A Methods for genotype screening
US7494817B2 (en) 2000-09-06 2009-02-24 Transnet Yx, Inc. Methods for genotype screening using magnetic particles
EP1978110B1 (en) 2000-09-06 2010-05-26 Transnetyx, Inc. Computer-based method and system for screening genomic DNA
US20050272085A1 (en) 2000-09-06 2005-12-08 Hodge Timothy A Methods for forensic and congenic screening
US20030087286A1 (en) 2000-09-06 2003-05-08 Hodge Timothy A. Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
US20030207289A1 (en) 2001-09-04 2003-11-06 Hodge Timothy A. Detection of genetic sequences using a bipartite probe
WO2002025289A1 (en) 2000-09-18 2002-03-28 I-Card Corporation Micro well array and method of sealing liquid using the micro well array
IL138988A (en) * 2000-10-12 2005-09-25 Yissum Res Dev Co Dendritically amplified detection method
US20040018491A1 (en) * 2000-10-26 2004-01-29 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
US7045367B2 (en) * 2001-03-23 2006-05-16 Michigan Molecular Institute Nano-scaled dendrimer-based colorimetric biosensors
US20060014186A1 (en) 2001-09-04 2006-01-19 Hodge Timothy A Methods for genotype screening of a strain disposed on an adsorbent carrier
EP1439862A4 (en) * 2001-10-31 2005-05-18 Millennium Pharm Inc Methods and compositions for the treatment and diagnosis of pain disorders using 9805
US7163790B2 (en) * 2001-11-28 2007-01-16 Bio-Rad Laboratories, Inc. Parallel polymorphism scoring by amplification and error correction
US20040023248A1 (en) * 2001-12-07 2004-02-05 Whitehead Institiute For Biomedical Research Methods and reagents for improving nucleic acid detection
WO2004031408A1 (en) * 2002-09-30 2004-04-15 F.Hoffmann-La Roche Ag Oligonucleotides for genotyping thymidylate synthase gene
US7354706B2 (en) * 2003-09-09 2008-04-08 The Regents Of The University Of Colorado, A Body Corporate Use of photopolymerization for amplification and detection of a molecular recognition event
JP2007512811A (en) * 2003-11-10 2007-05-24 インベスチゲン， インコーポレイテッド Methods for preparing nucleic acids for detection

Also Published As

Publication number Publication date
US7282361B2 (en) 2007-10-16
US7011943B2 (en) 2006-03-14
TW200745346A (en) 2007-12-16
EP1978110A1 (en) 2008-10-08
TWI313713B (en) 2009-08-21
EP1978110B1 (en) 2010-05-26
US20050170423A1 (en) 2005-08-04
US20050221370A1 (en) 2005-10-06
WO2003020985A1 (en) 2003-03-13
US20030165922A1 (en) 2003-09-04
US20020177137A1 (en) 2002-11-28
US6977178B2 (en) 2005-12-20
TWI322187B (en) 2010-03-21

Similar Documents

Publication Publication Date Title
WO2003020985B1 (en) Detection of genetic sequences using a bipartite probe
US10900033B2 (en) Method of nonspecific target capture of nucleic acids
US6811977B2 (en) Rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping
EP1880206B1 (en) Multiplex capture of nucleic acids
US6821724B1 (en) Methods of genetic analysis using nucleic acid arrays
JP5020818B2 (en) Methods and compositions for detecting nucleic acids in biological samples
EP1247815A2 (en) Modified oligonucleotides and uses thereof
US20120157348A1 (en) Detection of nucleic acids from whole
US20110195864A1 (en) Assays for determining telomere length and repeated sequence copy number
US9663822B2 (en) Multiplex capture of nucleic acids
WO2001092572A1 (en) Kit and method for determining hla type
CA2286573A1 (en) Nucleic acid archiving
JPH11514850A (en) Nucleic acid detection method using nucleotide probe capable of specific capture and detection
CA2505254A1 (en) Universal tag assay
WO2001075166A3 (en) Compositions and methods for detecting and quantifying gene expression
WO2008109945A1 (en) Analysis of ribonucleic acid
CA2067426A1 (en) Membrane bound probes
CA2249643A1 (en) Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis nucleic acid
AU2006219362B2 (en) Assist probes and method of using the same
CA2747479A1 (en) Methods and reagents for shortening incubation times in hybridization assays
WO2002083949A1 (en) A method for detecting hybridized nucleic acid with improved sensitivity
CN1926244B (en) Analysis chip with reference scale, kits and analytical methods
Berggren et al. Multiplexed gene expression analysis using the invader RNA assay with MALDI-TOF mass spectrometry detection
EP1956098A1 (en) Method of detecting gene mutation
CN113025690B (en) Nucleic acid probe group and application thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

B Later publication of amended claims

Free format text: 20030304

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP